Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-485232 in Metastatic Melanoma
NCT00107718Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Primary completion
- May 2006
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of iboctadekin in melanoma, sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
iboctadekin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00107718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107718.